MICROBOT MEDICAL INC.: 10-Q filed 2021-08-16
What MICROBOT MEDICAL INC. reported in its quarterly report filed 2021-08-16 (fiscal Q2 2021): 27 published measures, 67 facts as tagged in accession 0001493152-21-020178.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2021-08-16
- Fiscal period
- fiscal Q2 2021
- Accession
- 0001493152-21-020178 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MICROBOT MEDICAL INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 21,865,000 | USD | |
| At 2020-12-31 | 26,279,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 1,747,000 | USD | |
| At 2020-12-31 | 1,971,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 20,118,000 | USD | |
| At 2021-03-31 | 22,330,000 | USD | |
| At 2020-12-31 | 24,308,000 | USD | |
| At 2020-06-30 | 28,389,000 | USD | |
| At 2020-03-31 | 29,678,000 | USD | |
| At 2019-12-31 | 31,540,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 15,619,000 | USD | |
| At 2020-12-31 | 19,650,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -2,511,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -4,899,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -1,855,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -4,060,000 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | -4,291,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | -3,688,000 | USD | 182 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 11,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 76,000 | USD | 182 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-01-01 to 2020-06-30 | -3,375,000 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 259,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 2,245,000 | USD | 182 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | -49,179,000 | USD | |
| At 2020-12-31 | -44,280,000 | USD |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 230,000 | USD | |
| At 2020-12-31 | 251,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 709,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 909,000 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -2,476,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -4,868,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -1,884,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -4,047,000 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 20,961,000 | USD | |
| At 2020-12-31 | 25,253,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 1,204,000 | USD | |
| At 2020-12-31 | 1,345,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 347,000 | USD | |
| At 2020-12-31 | 275,000 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 1,389,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 2,508,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 669,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 1,360,000 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 7,108,133 | shares | |
| At 2020-12-31 | 7,108,133 | shares |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 674,000 | USD | |
| At 2020-12-31 | 775,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 708,000 | USD | |
| At 2020-12-31 | 813,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 692,000 | USD | |
| At 2020-12-31 | 883,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2021-06-30 | 260,000 | USD | |
| At 2020-12-31 | 521,000 | USD |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | -2,511,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -4,899,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | -1,855,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | -4,060,000 | USD | 182 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-04-01 to 2021-06-30 | 1,087,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 2,360,000 | USD | 181 |
| 2020-04-01 to 2020-06-30 | 1,215,000 | USD | 91 |
| 2020-01-01 to 2020-06-30 | 2,687,000 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 32,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 34,000 | USD | 182 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 2,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 8,000 | USD | 182 |
Operating lease payments
Cash paid for operating lease liabilities during the period. It differs from lease expense recognized and excludes variable payments in some presentations.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2021-01-01 to 2021-06-30 | 127,000 | USD | 181 |
| 2020-01-01 to 2020-06-30 | 52,000 | USD | 182 |
Inspect the source
- Entity
- MICROBOT MEDICAL INC. / CIK 0000883975
- Captured
- 2026-09-20T05:02:19.185Z
- SEC response SHA-256
5fc792c757c83821aa0cd636b3655419924829213ef914d8be1d9f56dce19054
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000883975.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))